Paper Details

  1. Home
  2. Paper Details

Tacrolimus effect on rosacea.

Author: BamfordJoel T M, ElliottBarbara A, HallerIrina V

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

A 12-week open-label trial involving 24 patients with erythrotelangiectatic or papulopustular rosacea demonstrated that 0.1% tacrolimus topical ointment significantly improved erythema in both rosacea subtypes. However, it did not reduce the number of papulopustular lesions. Side effects were consistent with those reported in the tacrolimus topical ointment labeling.
Paper Details　
Original Abstract of the Article :
Twenty-four patients with erythrotelangiectatic or papulopustular rosacea were treated with 0.1% tacrolimus topical ointment in a 12-week open-label trial. Erythema was significantly improved in both rosacea subtypes (P<.05). There was no decrease in the number of papulopustular lesions. Side effect...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/14699377

データ提供：米国国立医学図書館（NLM）

Tacrolimus: A Potential Treatment for Rosacea

Rosacea, a common skin condition, can cause significant discomfort and affect a person's self-esteem. This study investigates the potential of tacrolimus, a topical ointment, as a treatment option for rosacea. The researchers conducted a 12-week trial, evaluating the effectiveness of tacrolimus in reducing erythema, a hallmark symptom of rosacea.

Tacrolimus Shows Promise in Reducing Rosacea Erythema

The study's findings demonstrate that tacrolimus topical ointment effectively reduces erythema in both subtypes of rosacea: erythrotelangiectatic and papulopustular. This finding suggests that tacrolimus holds promise as a treatment option for managing this common skin condition.

Navigating the Side Effects of Tacrolimus

While tacrolimus shows potential, it's crucial to be aware of its potential side effects. Like a camel navigating a desert with its own unique challenges, individuals considering tacrolimus treatment should discuss potential side effects with their healthcare provider.

Dr.Camel's Conclusion

This study provides encouraging evidence for the use of tacrolimus as a potential treatment for rosacea. Further research is needed to fully understand the long-term effects and optimal use of this drug.

Date :
  1. Date Completed 2004-02-27
  2. Date Revised 2019-07-09
Further Info :

Pubmed ID

14699377

DOI: Digital Object Identifier

S0190962203021571

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.